Related Experiment Video
Updated: Aug 8, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C
Katia Falasca1, Claudio Ucciferri, Margherita Dalessandro
1Clinic of Infectious Diseases, Dept. of Medicine and Aging, University G. DAnnunzio, Chieti, Italy.
Insights
Hepatitis B virus (HBV) infection shows higher Th1 cytokine levels than hepatitis C virus (HCV) infection. Interleukin-6 and Interleukin-18 indicate inflammation and liver injury in both chronic hepatitis B and C.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- T-cell immunoregulatory cytokines impact chronic hepatitis C virus (HCV) persistence and liver damage.
- Th1 cytokines correlate with hepatic inflammation in chronic hepatitis B virus (HBV) infection.
- Interleukin-6 (IL-6) and Interleukin-18 (IL-18) are implicated in viral clearance and hepatic diseases.
Purpose of the Study:
- To evaluate the Th1/Th2 cytokine profile in patients with HCV and HBV hepatitis.
- To compare cytokine levels between HCV, HBV, and healthy control groups.
Main Methods:
- Plasma cytokine levels (IFN-gamma, TNF-alpha, IL-2, IL-6, IL-18) were measured in patients with HCV, HBV, and controls.
- Correlations between cytokine levels, disease duration, viral load, and liver enzymes (ALT, AST) were analyzed.
Main Results:
- HBV patients exhibited significantly higher plasma IFN-gamma, TNF-alpha, and IL-2 levels compared to HCV patients and controls.
- Both HCV and HBV patients showed elevated IL-6 and IL-18 levels compared to controls.
- IL-6 correlated positively with disease duration and viral load in both HCV and HBV groups.
- IL-18 correlated positively with ALT and AST levels in both HCV and HBV groups.
Conclusions:
- Patients with chronic hepatitis B demonstrate higher levels of Th1 cytokines compared to those with chronic hepatitis C.
- Elevated IL-6 and IL-18 levels serve as important indicators of inflammation and hepatic injury in both HCV and HBV infections, particularly in hepatitis C.
Abstract:
T-cell immunoregulatory cytokines influence the persistence of hepatitis C virus (HCV) chronic infection and the extent of liver damage. Th1 cytokines positively correlate with hepatic inflammation in chronic hepatitis B virus (HBV) infection. The pro-inflammatory, cytokines IL-6 and IL-18, are involved in viral clearance and in metabolic and viral hepatic diseases, respectively. The aim of this study was to evaluate the profile of Th1/Th2 cytokines in HCV and HBV hepatitis. HBV-infected patients showed higher plasma IFN-gamma levels than the HCV+ patients or the control group (p <0.0001). Plasma TNF-alpha and IL-2 were higher in HBV+ in comparison to HCV+ patients (p <0.001) or the control group (p <0.005). Plasma IL-6 and IL-18 were higher in both groups of patients compared to the control group (p <0.04). In HCV+ and HBV+ groups, IL-6 was positively correlated with the duration of the illness (p <0.01 and <0.001, respectively) and viral load (p <0.001 and <0.001, respectively), while IL-18 was positively correlated with serum ALT activity (p <0.01 and <0.001, respectively) and serum AST activity (p <0.01 and <0.001, respectively). We found that in HCV+ and HBV+ patients there are higher levels of Th1 cytokines, particularly in the course of chronic hepatitis B, and that IL-18 and IL-6 levels may have important roles as markers of both inflammation and hepatic injury, particularly in the course of hepatitis C.
Related Concept Videos
Hepatitis
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Viral Hepatitis I: Introduction

